Advertisement
Screener

ORAGENICS, INC. (OGEN) Proceeds from Issuance of Private Placement

0.9 / 5 stars · 10/53 Roast Me

ORAGENICS, INC. Proceeds from Issuance of Private Placement

ORAGENICS, INC. (OGEN) reported Proceeds from Issuance of Private Placement of $6.67 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-14.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-03-14

  • ORAGENICS, INC. proceeds from issuance of private placement for the quarter ending 2023-12-31 was $118.00.
  • ORAGENICS, INC. proceeds from issuance of private placement for fiscal 2024 was $6.67M, a 684.99% increase from fiscal 2023.
  • ORAGENICS, INC. proceeds from issuance of private placement for fiscal 2023 was $849.93K, a 1126.64% increase from fiscal 2022.
  • ORAGENICS, INC. proceeds from issuance of private placement for fiscal 2022 was $69.29K.
Period endProceeds from Issuance of Private Placement 3 monthProceeds from Issuance of Private Placement 9 monthProceeds from Issuance of Private Placement 12 month
2024-12-31$6.67M
10-K · filed 2025-03-14
2023-12-31$118.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
$849.93K
10-K · filed 2025-03-14
2023-09-30$849.81K
10-Q · filed 2023-11-09
2022-12-31$69.29K
10-K · filed 2024-03-29
2013-12-31$3.90M
10-Q · filed 2015-08-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02